Carrie Brownstein Zentalis Pharmaceuticals, Inc. (ZNTL) insider trading activity

Carrie Brownstein is Chief Medical Officer of Zentalis Pharmaceuticals, Inc.. Currently has a direct ownership of 105,685 shares of ZNTL, which is worth approximately $402,659. The most recent transaction as insider was on Oct 04, 2023, when has been sold 10,628 shares (Common Stock) at a price of $19.67 per share, resulting in proceeds of $209,052. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 106K

0% 3M change

0% 12M change

Total Value Held $402,659

Carrie Brownstein Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 04 2023	SELL Open market or private sale	$209,052 $19.67 p/Share	10,628 Reduced 9.14%	105,685 Common Stock
Feb 01 2023	BUY Grant, award, or other acquisition	-	16,313 Added 12.3%	116,313 Common Stock
Oct 03 2022	BUY Grant, award, or other acquisition	-	100,000 Added 50.0%	100,000 Common Stock

Also insider at

STTK

Shattuck Labs, Inc. Healthcare